Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

VIVSVivoSim Labs, INC.

Nasdaq · CIK 0001497253
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end0331
XBRL facts414

Identity from submissions API

NameVivoSim Labs, INC.
CIK0001497253
TickersVIVS
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN271488943
LEI—
Fiscal year end0331
State of incorporationDE DE
Phone858-224-1000
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • ORGANOVO HOLDINGS, INC. (2012-01-04T05:00:00.000Z → 2025-04-23T04:00:00.000Z)
  • REAL ESTATE RESTORATION & RENTAL, INC. (2010-08-04T04:00:00.000Z → 2011-10-31T04:00:00.000Z)
Business address
11555 SORRENTO VALLEY ROAD
SUITE 100
SAN DIEGO
CA
92121
CA
Mailing address
11555 SORRENTO VALLEY ROAD
SUITE 100
SAN DIEGO
CA
92121
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

820 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-12 10-Q 10-Q 0001193125-26-458330 001-35996 261546895 34 9605495 1 1
2026-10-16 8-K 8-K 1.01,9.01 0001193125-26-424061 001-35996 261466102 34 217774 1 1
2026-10-06 8-K 8-K 5.02,5.07,9.01 0001193125-26-415542 001-35996 261444017 34 459524 1 1
2026-09-01 4 4 0001193125-26-378358 4759
2026-08-21 ARS ARS 0001193125-26-361092 001-35996 261304704 34 476146
2026-08-21 8-K 8-K 3.01,9.01 0001193125-26-361085 001-35996 261304684 34 160573 1 1
2026-08-21 DEF 14A DEF 14A 0001193125-26-361066 001-35996 261304621 34 2510118 1 1
2026-08-17 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-098000 005-86817 261288239 34 9347
2026-08-13 PRER14A PRER14A 0001193125-26-349548 001-35996 261274697 34 2463502 1 1
2026-08-12 10-Q 10-Q 0001193125-26-346820 001-35996 261267465 34 7590316 1 1
2026-08-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002599 333-297892 261260464 33 1994
2026-08-10 PRE 14A PRE 14A 0001193125-26-341405 001-35996 261256440 34 2450420 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001193125-26-336844 001-35996 261246138 34 182411 1 1
2026-07-31 S-1 S-1 0001193125-26-328613 333-297892 261228740 33 454568 1 1
2026-07-30 8-K 8-K 5.08,8.01,9.01 0001193125-26-326139 001-35996 261223443 34 141526 1 1
2026-07-24 8-K CURRENT REPORT 3.01,8.01,9.01 0001213900-26-081377 001-35996 261201567 34 198918 1 1
2026-07-17 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-26-306849 001-35996 261181938 34 678804 1 1
2026-07-14 10-K 10-K 0001193125-26-303316 001-35996 261174794 34 11692313 1 1
2026-06-29 NT 10-K NT 10-K 0001193125-26-288413 001-35996 261135710 34 62889
2026-04-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-039856 005-86817 26840376 34 10045
2026-04-03 8-K 8-K 1.01,8.01,9.01 0001193125-26-142106 001-35996 26838087 34 217050 1 1
2026-04-02 424B4 PROSPECTUS 0001213900-26-039307 333-294716 26833149 33 478719
2026-03-31 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001032 333-294716 26824494 33 1993
2026-03-31 CORRESP filename1.htm 0001213900-26-037179 6382
2026-03-31 CORRESP filename1.htm 0001213900-26-037177 8427
2026-03-31 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-26-037009 333-294716 26818280 33 846166 1 1
2026-03-30 CORRESP filename1.htm 0001213900-26-036734 6687
2026-03-30 CORRESP filename1.htm 0001213900-26-036732 5153
2026-03-27 CORRESP filename1.htm 0001213900-26-035818 6528
2026-03-27 CORRESP filename1.htm 0001213900-26-035817 7733
2026-03-27 S-1 REGISTRATION STATEMENT 0001213900-26-035742 333-294716 26808707 33 1476951 1 1
2026-03-13 UPLOAD filename1.pdf 0000000000-26-002619 377-09122 40610
2026-03-09 DRS filename1.htm 0001213900-26-025034 377-09122 26733788 33 568700
2026-02-11 10-Q 10-Q 0001193125-26-046520 001-35996 26620689 34 8470237 1 1
2026-01-29 4 4 0001193125-26-029889 18101
2026-01-29 4 4 0001193125-26-029888 17346
2026-01-29 4 4 0001193125-26-029881 15000
2026-01-29 4 4 0001193125-26-029879 14314
2026-01-29 4 4 0001193125-26-029875 17316
2025-12-18 8-K 8-K 5.07,9.01 0001193125-25-324794 001-35996 251583060 34 188052 1 1
2025-11-26 4 4 0001193125-25-300907 5534
2025-11-26 3 3 0001193125-25-300904 14572
2025-11-19 4 4 0001193125-25-288076 4850
2025-11-06 ARS ARS 0001193125-25-269996 001-35996 251459299 34 563348
2025-11-06 10-Q 10-Q 0001193125-25-269483 001-35996 251458265 34 8176959 1 1
2025-11-03 DEFA14A DEFA14A 0001193125-25-262551 001-35996 251444124 34 3721518
2025-11-03 DEF 14A DEF 14A 0001193125-25-262543 001-35996 251444093 34 10335878 1 1
2025-09-26 RW WITHDRAWAL REQUEST 0001213900-25-091788 333-282841 251345033 NE 7902
2025-08-28 S-8 S-8 0001193125-25-191220 333-289913 251273200 33 220217 1 1
2025-08-21 4 4 0000950170-25-110771 5536
2025-08-21 3 3 0001193125-25-185525 14273
2025-08-14 8-K 8-K 5.02,7.01,9.01 0000950170-25-108447 001-35996 251214481 34 252034 1 1
2025-08-12 10-Q 10-Q 0000950170-25-107284 001-35996 251206600 34 7013206 1 1
2025-07-29 10-K/A 10-K/A 0000950170-25-099620 001-35996 251161847 34 985301 1 1
2025-06-05 10-K 10-K 0000950170-25-082312 001-35996 251027106 34 11988550 1 1
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-002278 005-86817 25952011 34 10835
2025-05-06 8-K 8-K 8.01,9.01 0000950170-25-063979 001-35996 25915322 34 165073 1 1
2025-04-24 8-K 8-K 5.03,7.01,8.01,9.01 0000950170-25-057685 001-35996 25863711 34 529632 1 1
2025-04-23 8-K 8-K 7.01,9.01 0000950170-25-056974 001-35996 25859257 34 172386 1 1
2025-04-11 424B5 PROSPECTUS 0001213900-25-030814 333-276722 25830203 33 22282
2025-04-02 8-K 8-K 2.02,7.01,8.01,9.01 0000950170-25-048888 001-35996 25802245 34 202785 1 1
2025-03-27 8-K 8-K 7.01,9.01 0000950170-25-045740 001-35996 25775406 34 189659 1 1
2025-03-26 8-K 8-K 2.01,5.02,8.01,9.01 0000950170-25-044801 001-35996 25770235 34 187582 1 1
2025-03-21 8-K 8-K 3.03,5.03,9.01 0000950170-25-042903 001-35996 25758564 34 189891 1 1
2025-03-19 8-K 8-K 7.01,9.01 0000950170-25-041749 001-35996 25750899 34 189404 1 1
2025-03-06 8-K 8-K 8.01,9.01 0000950170-25-034181 001-35996 25713658 34 183036 1 1
2025-02-26 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-017214 333-276722 25665926 33 22926
2025-02-25 8-K 8-K 1.01,3.01,8.01,9.01 0000950170-25-026097 001-35996 25659490 34 984111 1 1
2025-02-19 10-Q 10-Q 0000950170-25-022778 001-35996 25637595 34 9082186 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001260 005-86817 25630909 34 10695
2025-02-14 NT 10-Q NT 10-Q 0001193125-25-027253 001-35996 25628290 34 23989
2025-01-17 8-K 8-K 3.01,9.01 0000950170-25-006819 001-35996 25539714 34 161201 1 1
2025-01-08 3 3 0000950170-25-003431 13769
2024-12-31 8-K 8-K 5.02,9.01 0000950170-24-141323 001-35996 241591205 34 202012 1 1
2024-11-22 8-K 8-K 5.02,5.07,9.01 0000950170-24-129965 001-35996 241486498 34 480939 1 1
2024-11-14 SC 13G armistice-onvo093024.htm 0001172661-24-005099 005-86817 241461071 34 90584
2024-11-08 10-Q 10-Q 0000950170-24-124044 001-35996 241440426 34 7918676 1 1
2024-10-25 S-1 S-1 0000950170-24-117458 333-282841 241397745 33 781104
2024-10-07 ARS ARS 0000950170-24-113215 001-35996 241357847 34 1164180
2024-10-07 DEFA14A DEFA14A 0000950170-24-113214 001-35996 241357838 34 1407013
2024-10-07 DEF 14A DEF 14A 0000950170-24-113206 001-35996 241357826 34 4062040 1 1
2024-09-18 PRE 14A PRE 14A 0000950170-24-107771 001-35996 241307455 34 4103224 1 1
2024-08-09 8-K 8-K 5.02,9.01 0000950170-24-094736 001-35996 241192529 34 155942 1 1
2024-08-09 4 4 0000950170-24-094726 4814
2024-08-09 4 4 0000950170-24-094725 6195
2024-08-09 4 4 0000950170-24-094724 4838
2024-08-09 4 4 0000950170-24-094723 4842
2024-08-09 4 4 0000950170-24-094722 4864
2024-08-07 4 4 0000950170-24-092719 9408
2024-08-05 10-Q 10-Q 0000950170-24-090726 001-35996 241174723 34 6627401 1 1
2024-07-26 10-K/A 10-K/A 0000950170-24-086880 001-35996 241146790 34 678591
2024-07-24 8-K 8-K 3.01,9.01 0000950170-24-086026 001-35996 241138090 34 161130 1 1
2024-05-31 10-K 10-K 0000950170-24-067301 001-35996 241009633 34 9125797 1 1
2024-05-14 424B4 424B4 0000950170-24-059277 333-278668 24942568 33 3316794
2024-05-13 8-K 8-K 1.01,8.01,9.01 0000950170-24-058805 001-35996 24940050 34 1063079 1 1
2024-05-10 424B4 424B4 0000950170-24-057960 333-278668 24936007 33 3314487
2024-05-08 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-05-08 17:30:00 9999999995-24-001429 333-278668 24928284 33 1910
2024-05-03 CORRESP filename1.htm 0001193125-24-130850 6800
2024-05-03 CORRESP filename1.htm 0001193125-24-130848 7726
2024-05-01 8-K 8-K 7.01,9.01 0000950170-24-050906 001-35996 24900154 34 12902237 1 1
2024-04-30 S-1/A S-1/A 0000950170-24-050663 333-278668 24898757 33 13168647 1 1
2024-04-23 8-K 8-K 8.01,9.01 0000950170-24-046879 001-35996 24864817 34 158710 1 1
2024-04-17 UPLOAD filename1.pdf 0000000000-24-004215 333-278668 40456
2024-04-12 S-1 S-1 0000950170-24-044137 333-278668 24842388 33 12150205 1 1
2024-02-12 SC 13G/A SC 13G/A 0001140361-24-007104 005-86817 24621819 34 70294
2024-02-08 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-02-08 16:30:00 9999999995-24-000359 333-276722 24610958 33 1910
2024-02-08 424B5 424B5 0001193125-24-028469 333-276722 24609924 33 321901
2024-02-08 10-Q 10-Q 0000950170-24-012754 001-35996 24608991 34 6636951 1 1
2024-02-07 8-K 8-K 7.01,9.01 0000950170-24-011954 001-35996 24602252 34 9508945 1 1
2024-02-06 CORRESP filename1.htm 0001193125-24-025284 6745
2024-02-05 SC 13G/A AMENDMENT NO. 4 0001214659-24-001845 005-86817 24593847 34 63735
2024-02-02 UPLOAD filename1.pdf 0000000000-24-001327 333-276722 40463
2024-01-26 S-3 S-3 0001193125-24-016839 333-276722 24568842 33 1048103
2023-12-28 8-K 8-K 3.02,8.01,9.01 0000950170-23-073581 001-35996 231522760 34 162952 1 1
2023-12-22 424B5 424B5 0001193125-23-301722 333-252224 231507081 33 20410
2023-12-01 S-8 S-8 0001193125-23-287453 333-275845 231459554 33 100002
2023-11-17 4 4 0000950170-23-064956 4757
2023-11-17 4 4 0000950170-23-064954 4753
2023-11-17 4 4 0000950170-23-064952 6110
2023-11-17 4 4 0000950170-23-064947 4774
2023-11-17 4 4 0000950170-23-064944 6620
2023-11-17 4 4 0000950170-23-064942 4779
2023-11-15 144 xsl144X01/primary_doc.xml 0001974078-23-000202 001-35996 231411131 33 4372
2023-11-09 10-Q 10-Q 0000950170-23-062228 001-35996 231393709 34 6783024 1 1
2023-11-03 8-K 8-K 5.02,5.07,9.01 0000950170-23-058528 001-35996 231374538 34 387809 1 1
2023-09-22 8-K/A 8-K/A 2.05,5.02,9.01 0000950170-23-049425 001-35996 231271730 34 252094 1 1
2023-09-13 ARS ARS 0000950170-23-047968 001-35996 231253365 34 1416673
2023-09-13 DEF 14A DEF 14A 0000950170-23-047966 001-35996 231253363 34 4700665 1 1
2023-09-13 DEFA14A DEFA14A 0000950170-23-047964 001-35996 231253358 34 1304814
2023-09-12 8-K 8-K 5.02,9.01 0000950170-23-047720 001-35996 231250212 34 227685 1 1
2023-09-05 8-K 8-K 4.01,9.01 0001193125-23-228012 001-35996 231233987 34 145649 1 1
2023-08-22 8-K 8-K 2.05,5.02,9.01 0001193125-23-218056 001-35996 231194059 34 149298 1 1
2023-08-10 10-Q 10-Q 0000950170-23-041307 001-35996 231159350 34 6164652 1 1
2023-07-31 10-K/A 10-K/A 0000950170-23-035933 001-35996 231127425 34 1459319 1 1
2023-07-24 8-K 8-K 4.01,9.01 0001193125-23-192276 001-35996 231105305 34 152203 1 1
2023-07-14 PRE 14A PRE 14A 0000950170-23-033052 001-35996 231089734 34 5006693 1 1
2023-07-14 10-K 10-K 0000950170-23-032889 001-35996 231087721 34 13094741 1 1
2023-06-29 NT 10-K NT 10-K 0001193125-23-178582 001-35996 231057438 34 22935
2023-03-15 8-K 8-K 1.01,9.01 0001193125-23-071465 001-35996 23736135 34 143485 1 1
2023-02-10 SC 13G/A SC 13G/A 0001140361-23-005794 005-86817 23609171 34 65653
2023-02-09 10-Q 10-Q 0000950170-23-002327 001-35996 23606235 34 7486313 1 1
2023-02-03 SC 13G/A AMENDMENT NO. 3 0001214659-23-001566 005-86817 23583647 34 63498
2022-11-14 4 FORM 4 SUBMISSION 0000899243-22-035799 4925
2022-11-14 4 FORM 4 SUBMISSION 0000899243-22-035798 4953
2022-11-14 4 FORM 4 SUBMISSION 0000899243-22-035796 4988
2022-11-14 4 FORM 4 SUBMISSION 0000899243-22-035795 4949
2022-11-14 4 FORM 4 SUBMISSION 0000899243-22-035794 6306
2022-11-14 4 FORM 4 SUBMISSION 0000899243-22-035792 4975
2022-11-10 10-Q 10-Q 0001564590-22-037381 001-35996 221377135 34 5928495 1 1
2022-10-25 S-8 POS S-8 POS 0001193125-22-268412 333-260910 221329916 33 105349
2022-10-25 S-8 POS S-8 POS 0001193125-22-268410 333-226839 221329911 33 105349
2022-10-25 S-8 POS S-8 POS 0001193125-22-268407 333-209395 221329894 33 105349
2022-10-25 S-8 POS S-8 POS 0001193125-22-268406 333-192248 221329874 33 105349
2022-10-25 S-8 POS S-8 POS 0001193125-22-268405 333-181324 221329863 33 105349
2022-10-25 S-8 S-8 0001193125-22-268353 333-268001 221329519 33 289977
2022-10-20 4 FORM 4 SUBMISSION 0000899243-22-033857 5537
2022-10-20 4 FORM 4 SUBMISSION 0000899243-22-033856 5458
2022-10-20 4 FORM 4 SUBMISSION 0000899243-22-033855 5445
2022-10-14 8-K 8-K 5.02,5.07,9.01 0001564590-22-034280 001-35996 221311432 34 563399 1 1
2022-09-22 DEFA14A DEFA14A 0001564590-22-032139 001-35996 221259330 34 1011037
2022-09-22 DEFR14A DEFR14A 0001564590-22-032135 001-35996 221259284 34 2458100
2022-09-06 8-K 8-K 8.01,9.01 0001564590-22-031015 001-35996 221226919 34 231358 1 1
2022-08-11 10-Q 10-Q 0001564590-22-029133 001-35996 221156205 34 4900949 1 1
2022-07-26 DEFA14A DEFA14A 0001564590-22-026511 001-35996 221107797 34 2231571
2022-07-26 DEF 14A DEF 14A 0001564590-22-026510 001-35996 221107782 34 3596402
2022-07-08 5 FORM 5 SUBMISSION 0000899243-22-025824 5233
2022-06-10 10-K 10-K 0001564590-22-022994 001-35996 221009095 34 8625914 1 1
2022-03-10 4 FORM 4 SUBMISSION 0000899243-22-010448 5435
2022-03-10 3 FORM 3 SUBMISSION 0000899243-22-010444 6527
2022-03-10 8-K 8-K 5.02,9.01 0001564590-22-009633 001-35996 22729065 34 177349 1 1
2022-02-28 8-K 8-K 1.01,7.01,9.01 0001564590-22-007614 001-35996 22689384 34 251345 1 1
2022-02-14 10-Q 10-Q 0001564590-22-004952 001-35996 22631487 34 5364905 1 1
2022-02-14 SC 13G/A SC31G/A 0001140361-22-005035 005-86817 22624463 34 74112
2022-02-10 SC 13G/A onvo-13g_20211231.txt 0001037389-22-000071 005-86817 22615285 34 13445
2022-02-04 SC 13G/A AMENDMENT NO. 2 0001214659-22-001853 005-86817 22590828 34 63343
2021-11-19 8-K 8-K LEASE AMENDMENT 1.01,9.01 0001564590-21-057764 001-35996 211428357 34 2070612 1 1
2021-11-09 S-8 S-8 0001193125-21-324435 333-260910 211392106 33 89770
2021-11-08 10-Q 10-Q 0001564590-21-055246 001-35996 211387968 34 4702811 1 1
2021-11-01 3 FORM 3 SUBMISSION 0000899243-21-042265 6517
2021-10-12 4 FORM 4 SUBMISSION 0000899243-21-039915 5397
2021-10-12 4 FORM 4 SUBMISSION 0000899243-21-039914 5515
2021-10-12 4 FORM 4 SUBMISSION 0000899243-21-039913 10198
2021-10-12 4 FORM 4 SUBMISSION 0000899243-21-039911 5421
2021-10-12 4 FORM 4 SUBMISSION 0000899243-21-039910 10222
2021-10-12 4 FORM 4 SUBMISSION 0000899243-21-039909 5409
2021-10-12 4 FORM 4 SUBMISSION 0000899243-21-039908 5425
2021-10-06 8-K 8-K 5.02,5.07,9.01 0001564590-21-050320 001-35996 211310202 34 570068 1 1
2021-10-01 8-K 8-K 5.03,9.01 0001564590-21-049835 001-35996 211298907 34 177271 1 1
2021-09-17 DEFA14A DEFA14A 0001193125-21-276153 001-35996 211260608 34 36023
2021-09-17 8-K 8-K 8.01,9.01 0001193125-21-276145 001-35996 211260568 34 168163 1 1
2021-08-31 DEFA14A DEFA14A 0001564590-21-046435 001-35996 211224864 34 315919
2021-08-19 4 FORM 4 SUBMISSION 0000899243-21-033625 9131
2021-08-06 10-Q 10-Q 0001564590-21-042137 001-35996 211152920 34 3860180 1 1
2021-08-05 DEFA14A DEFA14A 0001564590-21-041707 001-35996 211149346 34 1510282
2021-08-05 DEF 14A DEF 14A 0001564590-21-041697 001-35996 211149261 34 2609280
2021-07-29 10-K/A 10-K/A 0001564590-21-039208 001-35996 211128353 34 1390466 1 1
2021-06-15 10-K 10-K 0001564590-21-032980 001-35996 211018547 34 7399397 1
2021-05-13 8-K 8-K 5.02 0001564590-21-027528 001-35996 21919562 34 42525
2021-04-19 8-K 8-K 5.02 0001564590-21-019401 001-35996 21834605 34 30001
2021-03-25 S-8 S-8 0001193125-21-094608 333-254714 21773459 33 173128
2021-03-10 4 FORM 4 SUBMISSION 0000899243-21-010985 7894
2021-03-10 4 FORM 4 SUBMISSION 0000899243-21-010984 5562
2021-03-10 4 FORM 4 SUBMISSION 0000899243-21-010982 12078
2021-03-10 8-K 8-K 5.02,9.01 0001193125-21-076214 001-35996 21729750 34 197129
2021-03-10 SC 13G/A SC 13G/A 0001104659-21-034413 005-86817 21729425 34 46171
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-024186 005-86817 21639396 34 44013
2021-02-11 SC 13G/A SC 13G/A 0001140361-21-004404 005-86817 21620953 34 72026
2021-02-11 SC 13G/A onvo-13g_20201231.txt 0001037389-21-000262 005-86817 21617728 34 13411
2021-02-08 10-Q 10-Q 0001564590-21-004687 001-35996 21601449 34 5650436 1
2021-02-05 SC 13G/A AMENDMENT NO. 1 0001214659-21-001383 005-86817 21593367 34 63335
2021-01-29 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2021-01-29 16:30:00 9999999995-21-000352 333-252224 21574133 33 1827
2021-01-29 424B5 424B5 0001193125-21-022748 333-252224 21571957 33 176366
2021-01-27 CORRESP filename1.htm 0001193125-21-018968 7515
2021-01-22 UPLOAD filename1.pdf 0000000000-21-000799 40299
2021-01-19 S-3 S-3 0001193125-21-011570 333-252224 21536228 33 1017092
2020-12-31 8-K 8-K 1.01,9.01 0001564590-20-058969 001-35996 201428900 34 185944
2020-12-11 4/A FORM 4/A SUBMISSION 0000899243-20-033636 6438
2020-11-25 8-K 8-K 1.01,9.01 0001564590-20-055281 001-35996 201352015 34 3360041
2020-11-05 10-Q 10-Q 0001564590-20-051311 001-35996 201290546 34 5682985 1
2020-10-09 SC 13G/A SC 13G/A 0001104659-20-113850 005-86817 201232903 34 46241
2020-09-21 8-K/A 8-K/A 5.07 0001564590-20-044050 001-35996 201185224 34 30526
2020-09-17 4 FORM 4 SUBMISSION 0001209191-20-051053 8341
2020-09-17 4 FORM 4 SUBMISSION 0001209191-20-051052 10730
2020-09-17 4 FORM 4 SUBMISSION 0001209191-20-051051 5469
2020-09-17 4 FORM 4 SUBMISSION 0001209191-20-051050 5379
2020-09-17 4 FORM 4 SUBMISSION 0001209191-20-051049 5563
2020-09-17 4 FORM 4 SUBMISSION 0001209191-20-051047 5476
2020-09-17 4 FORM 4 SUBMISSION 0001209191-20-051045 5355
2020-09-17 4 FORM 4 SUBMISSION 0001209191-20-051041 5367
2020-09-17 3 FORM 3 SUBMISSION 0001209191-20-051029 6004
2020-09-17 3 FORM 3 SUBMISSION 0001209191-20-051028 5978
2020-09-17 3 FORM 3 SUBMISSION 0001209191-20-051027 6086
2020-09-17 3 FORM 3 SUBMISSION 0001209191-20-051024 3056
2020-09-17 3 FORM 3 SUBMISSION 0001209191-20-051020 6549
2020-09-17 3 FORM 3 SUBMISSION 0001209191-20-051016 6566
2020-09-17 8-K 8-K 5.02,5.07,9.01 0001564590-20-043777 001-35996 201180134 34 129925
2020-09-03 DEFA14A DEFA14A 0001564590-20-042514 001-35996 201159340 34 122555
2020-09-03 8-K 8-K 3.01,5.02,9.01 0001564590-20-042513 001-35996 201159323 34 86936
2020-08-18 4 FORM 4 SUBMISSION 0001209191-20-047292 4999
2020-08-18 4 FORM 4 SUBMISSION 0001209191-20-047291 4964
2020-08-18 4 FORM 4 SUBMISSION 0001209191-20-047289 4984
2020-08-17 8-K 8-K 3.03,5.03,8.01,9.01 0001564590-20-040374 001-35996 201107980 34 68997
2020-08-17 DEFA14A DEFA14A 0001564590-20-040373 001-35996 201107979 34 47127
2020-08-10 10-Q 10-Q 0001564590-20-038895 001-35996 201089221 34 4178417 1
2020-08-06 DEFA14A DEFA14A 0001564590-20-037700 001-35996 201081426 34 207898
2020-08-06 DEF 14A DEF 14A 0001564590-20-037697 001-35996 201081415 34 1881379
2020-07-29 10-K/A 10-K/A 0001564590-20-034276 001-35996 201057347 34 1352587
2020-07-24 PRE 14A PRE 14A 0001564590-20-033385 001-35996 201046959 34 1861197
2020-07-22 3 FORM 3 SUBMISSION 0001209191-20-043396 6544
2020-07-22 3 PRIMARY DOCUMENT 0001818153-20-000001 2923
2020-07-15 8-K 8-K 1.01,5.02,9.01 0001193125-20-193012 001-35996 201028310 34 311490
2020-07-15 DEFA14A 8-K 0001193125-20-193013 001-35996 201028305 34 311215
2020-05-28 10-K 10-K 0001564590-20-027310 001-35996 20921094 34 7717009 1
2020-05-20 4 FORM 4 SUBMISSION 0001209191-20-031013 4998
2020-05-20 4 FORM 4 SUBMISSION 0001209191-20-031012 4963
2020-05-20 4 FORM 4 SUBMISSION 0001209191-20-031010 4983
2020-05-20 8-K 8-K 5.02,9.01 0001564590-20-026401 001-35996 20898848 34 57093
2020-04-08 8-K 8-K 1.02,5.07,8.01,9.01 0001564590-20-015914 001-35996 20782284 34 56665
2020-04-08 425 8-K 0001564590-20-015915 001-35996 20782266 34 57119
2020-04-01 425 425 0001564590-20-014671 001-35996 20763946 34 50413
2020-04-01 425 425 0001564590-20-014670 001-35996 20763932 34 23045
2020-04-01 8-K 8-K 8.01,9.01 0001564590-20-014668 001-35996 20763930 34 50909
2020-04-01 425 8-K 0001564590-20-014669 001-35996 20763921 34 51500
2020-03-27 8-K 8-K 5.07,8.01,9.01 0001564590-20-013657 001-35996 20752739 34 63780
2020-03-27 425 8-K 0001564590-20-013658 001-35996 20752721 34 64300
2020-03-20 425 425 0001193125-20-080840 001-35996 20732988 34 18194
2020-03-20 8-K 8-K 8.01,9.01 0001193125-20-080822 001-35996 20732910 34 61642
2020-03-20 425 8-K 0001193125-20-080824 001-35996 20732888 34 62233
2020-03-16 425 425 0001193125-20-075011 001-35996 20718063 34 17904
2020-03-16 425 425 0001193125-20-075007 001-35996 20718042 34 37789
2020-03-13 CT ORDER filename1.pdf 20200313,20200313 9999999997-20-001219 333-169928 20710842 34 122822
2020-03-03 SEC STAFF LETTER filename1.pdf 9999999997-20-001118 275889
2020-03-03 PX14A6G formpx14a6g.htm 0001493152-20-003257 001-35996 20681190 34 34857
2020-03-03 425 425 0001193125-20-059302 001-35996 20679210 34 5481688
2020-02-26 425 425 0001193125-20-049287 001-35996 20653408 34 34559
2020-02-26 425 425 0001193125-20-049281 001-35996 20653399 34 48045
2020-02-24 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2020-02-24 09:00:00 9999999995-20-000404 333-235683 20647089 33 1827
2020-02-24 424B3 424B3 0001193125-20-046655 333-235683 20645297 33 5744283
2020-02-20 4 FORM 4 SUBMISSION 0001209191-20-011304 5024
2020-02-20 4 FORM 4 SUBMISSION 0001209191-20-011302 4989
2020-02-20 4 FORM 4 SUBMISSION 0001209191-20-011300 5009
2020-02-20 CORRESP filename1.htm 0001193125-20-043672 8396
2020-02-20 S-4/A S-4/A 0001193125-20-043665 333-235683 20636298 33 702924
2020-02-14 SC 13G/A SCHEDULE 13G/A 0001104659-20-021153 005-86817 20616105 34 47736
2020-02-13 CORRESP filename1.htm 0001193125-20-034312 55700
2020-02-13 S-4/A S-4/A 0001193125-20-034294 333-235683 20607021 33 5871346
2020-02-12 SC 13G SC 13G 0001140361-20-002955 005-86817 20605338 34 68646
2020-02-12 SC 13G onvo-13g_20191231.txt 0001037389-20-000048 005-86817 20603171 34 13433
2020-02-12 SC 13G d27205sc13g.htm 0001214659-20-001200 005-86817 20599584 34 63001
2020-02-11 UPLOAD filename1.pdf 0000000000-20-001253 46661
2020-02-10 10-Q 10-Q 0001564590-20-004042 001-35996 20591934 34 6234109 1
2020-01-29 CORRESP filename1.htm 0001193125-20-017578 52552
2020-01-29 8-K 8-K 1.01,9.01 0001193125-20-017570 001-35996 20556288 34 43581
2020-01-29 425 8-K 0001193125-20-017572 001-35996 20556285 34 44168
2020-01-29 S-4/A S-4/A 0001193125-20-017553 333-235683 20556283 33 5960992
2020-01-21 UPLOAD filename1.pdf 0000000000-20-000493 62440
2020-01-21 PX14A6G formpx14a6g.htm 0001493152-20-000806 001-35996 20535006 34 29791
2020-01-09 SEC STAFF LETTER filename1.pdf 9999999997-20-000069 231163
2019-12-30 8-K 8-K 3.01,8.01 0001193125-19-325309 001-35996 191314724 34 28675
2019-12-30 425 8-K 0001193125-19-325310 001-35996 191314722 34 29226
2019-12-23 S-4 S-4 0001193125-19-322589 333-235683 191305997 33 9673595
2019-12-16 8-K 8-K 1.01,5.02,8.01,9.01 0001193125-19-314613 001-35996 191285969 34 816296
2019-12-16 425 8-K 0001193125-19-314614 001-35996 191285964 34 816686
2019-11-19 4 FORM 4 SUBMISSION 0001209191-19-057260 5016
2019-11-19 4 FORM 4 SUBMISSION 0001209191-19-057259 4981
2019-11-19 4 FORM 4 SUBMISSION 0001209191-19-057256 5001
2019-11-07 10-Q 10-Q 0001564590-19-041723 001-35996 191200315 34 6514004 1
2019-10-11 8-K 8-K 5.03,9.01 0001564590-19-036804 001-35996 191146822 34 35899
2019-10-03 8-K 8-K 8.01,9.01 0001564590-19-036322 001-35996 191134446 34 48355
2019-09-09 4 FORM 4 SUBMISSION 0001209191-19-048964 5607
2019-09-09 4 FORM 4 SUBMISSION 0001209191-19-048962 8528
2019-09-09 4 FORM 4 SUBMISSION 0001209191-19-048958 8507
2019-09-09 4 FORM 4 SUBMISSION 0001209191-19-048956 8510
2019-09-09 4 FORM 4 SUBMISSION 0001209191-19-048953 5567
2019-09-05 8-K 8-K 5.07 0001564590-19-034174 001-35996 191077246 34 58206
2019-08-19 4 FORM 4 SUBMISSION 0001209191-19-046694 5016
2019-08-19 4 FORM 4 SUBMISSION 0001209191-19-046693 8076
2019-08-19 4 FORM 4 SUBMISSION 0001209191-19-046691 5003
2019-08-19 4 FORM 4 SUBMISSION 0001209191-19-046690 4981
2019-08-19 4 FORM 4 SUBMISSION 0001209191-19-046689 5001
2019-08-08 10-Q 10-Q 0001564590-19-030763 001-35996 191009526 34 5171391 1
2019-08-07 8-K 8-K 8.01,9.01 0001564590-19-029710 001-35996 191004038 34 46778
2019-08-07 DEFA14A 8-K 0001564590-19-029711 001-35996 191004029 34 46698
2019-07-26 DEFA14A DEFA14A 0001564590-19-026251 001-35996 19975953 34 163731
2019-07-26 DEF 14A DEF 14A 0001564590-19-026250 001-35996 19975952 34 1754834
2019-07-10 4 FORM 4 SUBMISSION 0001209191-19-041714 10679
2019-07-10 SC 13G/A us68620a1043_071019.txt 0000215457-19-008307 005-86817 19949620 34 12256
2019-07-09 PRE 14A PRE 14A 0001564590-19-024687 001-35996 19947398 34 1622028
2019-07-09 8-K 8-K 5.02 0001564590-19-024686 001-35996 19947393 34 29766
2019-06-28 8-K 8-K 3.01 0001564590-19-023952 001-35996 19927344 34 27544
2019-06-03 10-K 10-K 0001564590-19-021444 001-35996 19873328 34 6853884 1
2019-05-22 8-K 8-K 2.02,9.01 0001564590-19-020163 001-35996 19845776 34 75088
2019-05-20 4 FORM 4 SUBMISSION 0001209191-19-031496 5326
2019-05-20 4 FORM 4 SUBMISSION 0001209191-19-031494 5300
2019-05-20 4 FORM 4 SUBMISSION 0001209191-19-031491 5289
2019-05-20 4 FORM 4 SUBMISSION 0001209191-19-031488 5292
2019-02-21 4 FORM 4 SUBMISSION 0001209191-19-012226 5328
2019-02-21 4 FORM 4 SUBMISSION 0001209191-19-012225 5303
2019-02-21 4 FORM 4 SUBMISSION 0001209191-19-012222 5291
2019-02-21 4 FORM 4 SUBMISSION 0001209191-19-012219 5294
2019-02-21 3 FORM 3 SUBMISSION 0001209191-19-012217 2969
2019-02-20 8-K 8-K 5.02,9.01 0001564590-19-003359 001-35996 19617127 34 64776
2019-02-14 SC 13G/A SC 13G/A 0001144204-19-007783 005-86817 19602926 34 42564
2019-02-07 10-Q FORM 10-Q 0001564590-19-002298 001-35996 19575572 34 5002522 1
2019-02-07 8-K 8-K 2.02,9.01 0001564590-19-002285 001-35996 19575319 34 497216
2019-02-06 SC 13G/A us68620a1043_020519.txt 0000215457-19-004910 005-86817 19571177 34 13240
2018-12-06 4 FORM 4 SUBMISSION 0001209191-18-061278 7806
2018-12-06 3 FORM 3 SUBMISSION 0001209191-18-061271 5985
2018-12-06 8-K 8-K 5.02,9.01 0001564590-18-030547 001-35996 181218950 34 53894
2018-11-27 8-K 8-K 5.02 0001564590-18-030139 001-35996 181203149 34 23703
2018-11-20 4 FORM 4 SUBMISSION 0001209191-18-059500 8308
2018-11-20 4 FORM 4 SUBMISSION 0001209191-18-059498 8285
2018-11-20 4 FORM 4 SUBMISSION 0001209191-18-059496 8257
2018-11-20 4 FORM 4 SUBMISSION 0001209191-18-059491 8254
2018-11-20 4 FORM 4 SUBMISSION 0001209191-18-059489 5295
2018-11-13 4 FORM 4 SUBMISSION 0001209191-18-058330 5136
2018-11-08 10-Q 10-Q 0001564590-18-028535 001-35996 181169702 34 4737201 1
2018-11-08 8-K 8-K 2.02,9.01 0001564590-18-028533 001-35996 181169661 34 470015
2018-08-16 4 FORM 4 SUBMISSION 0001209191-18-047204 7737
2018-08-16 4 FORM 4 SUBMISSION 0001209191-18-047201 7716
2018-08-16 4 FORM 4 SUBMISSION 0001209191-18-047200 7689
2018-08-16 4 FORM 4 SUBMISSION 0001209191-18-047197 7682
2018-08-16 4 FORM 4 SUBMISSION 0001209191-18-047195 7703
2018-08-15 4 FORM 4 SUBMISSION 0001209191-18-046894 7447
2018-08-15 8-K 8-K 5.02 0001564590-18-021837 001-35996 181021603 34 34961
2018-08-14 S-8 S-8 0001193125-18-248665 333-226839 181018944 33 75431
2018-08-14 S-8 S-8 0001193125-18-248656 333-226837 181018895 33 147680
2018-08-09 3 FORM 3 SUBMISSION 0001209191-18-046065 3050
2018-08-09 10-Q 10-Q 0001564590-18-021031 001-35996 181005046 34 4095061 1
2018-08-09 8-K 8-K 2.02,9.01 0001564590-18-021033 001-35996 181005008 34 405023
2018-07-30 4 FORM 4 SUBMISSION 0001209191-18-044422 5421
2018-07-30 4 FORM 4 SUBMISSION 0001209191-18-044421 5403
2018-07-30 4 FORM 4 SUBMISSION 0001209191-18-044420 5406
2018-07-30 4 FORM 4 SUBMISSION 0001209191-18-044419 5313
2018-07-30 4 FORM 4 SUBMISSION 0001209191-18-044418 5416
2018-07-30 4 FORM 4 SUBMISSION 0001209191-18-044417 5436
2018-07-27 8-K 8-K (ANNUAL MEETING RESULTS) 5.02,5.03,5.07,9.01 0001564590-18-017696 001-35996 18973476 34 189685
2018-06-26 4 FORM 4 SUBMISSION 0001209191-18-039515 7846
2018-06-15 DEFA14A DEFA14A 0001564590-18-015687 001-35996 18902285 34 172337
2018-06-15 DEF 14A DEF 14A 0001564590-18-015686 001-35996 18902254 34 3016366
2018-06-01 PRE 14A PRE 14A 0001564590-18-014954 001-35996 18876111 34 2810124
2018-05-31 8-K 8-K 2.02,9.01 0001564590-18-014816 001-35996 18871666 34 590968
2018-05-31 10-K 10-K 0001564590-18-014814 001-35996 18871624 34 7989130 1
2018-05-29 4 FORM 4 SUBMISSION 0001209191-18-033927 7873
2018-05-29 4 FORM 4 SUBMISSION 0001209191-18-033925 7846
2018-05-29 4 FORM 4 SUBMISSION 0001209191-18-033921 7822
2018-05-29 4 FORM 4 SUBMISSION 0001209191-18-033918 7845
2018-05-29 4 FORM 4 SUBMISSION 0001209191-18-033917 7835
2018-05-22 SC 13G/A SC 13G/A 0001144204-18-030226 005-86817 18851709 34 40861
2018-05-17 4 FORM 4 SUBMISSION 0001209191-18-031111 5317
2018-05-17 4 FORM 4 SUBMISSION 0001209191-18-031109 5292
2018-05-17 4 FORM 4 SUBMISSION 0001209191-18-031107 5266
2018-05-17 4 FORM 4 SUBMISSION 0001209191-18-031104 5279
2018-05-17 CT ORDER filename1.pdf 20180517,20180517 9999999997-18-005782 000-54621 18842252 34 16511
2018-03-23 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-18-086065,2018-03-23 9999999995-18-000660 333-202382 18711514 33 1866
2018-03-16 POS AM POS AM 0001193125-18-086065 333-202382 18696688 33 18854
2018-03-16 424B5 424B5 0001193125-18-086054 333-222929 18696649 33 410844
2018-03-16 8-K FORM 8-K 1.01,1.02,9.01 0001193125-18-086037 001-35996 18696612 34 215857
2018-02-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2018-02-22 16:00:00 9999999995-18-000482 333-222929 18634567 33 1853
2018-02-20 CORRESP filename1.htm 0001193125-18-050616 4957

Latest XBRL company facts

One latest value per concept from companyfacts (414 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 20.28M 2026-11-01 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
dei EntityPublicFloat Entity Public Float USD 7.54M 2025-09-30 2026 FY 10-K 2026-07-14 0001193125-26-303316
ecd AwardExrcPrice AwardExrcPrice USD/shares 1.78 2025-08-11 DEF 14A 2026-08-21 0001193125-26-361066
ecd AwardGrantDateFairValue AwardGrantDateFairValue USD 60,177 2025-08-11 DEF 14A 2026-08-21 0001193125-26-361066
ecd AwardUndrlygSecuritiesAmt AwardUndrlygSecuritiesAmt shares 40,000 2025-08-11 DEF 14A 2026-08-21 0001193125-26-361066
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 194,946 2025-04-01 2026-03-31 DEF 14A 2026-08-21 0001193125-26-361066
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 217,586 2025-04-01 2026-03-31 DEF 14A 2026-08-21 0001193125-26-361066
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 779,741 2025-04-01 2026-03-31 DEF 14A 2026-08-21 0001193125-26-361066
ecd PeoTotalCompAmt PeoTotalCompAmt USD 865,961 2025-04-01 2026-03-31 DEF 14A 2026-08-21 0001193125-26-361066
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 1.24 2025-04-01 2026-03-31 DEF 14A 2026-08-21 0001193125-26-361066
ecd UndrlygSecurityMktPriceChngPct UndrlygSecurityMktPriceChngPct pure 6.3 2025-08-11 DEF 14A 2026-08-21 0001193125-26-361066
ffd NetFeeAmt NetFeeAmt USD 451.93 2026-07-31 S-1 2026-07-31 0001193125-26-328613
ffd TtlFeeAmt TtlFeeAmt USD 451.93 2026-07-31 S-1 2026-07-31 0001193125-26-328613
ffd TtlOfferingAmt TtlOfferingAmt USD 3.27M 2026-07-31 S-1 2026-07-31 0001193125-26-328613
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-07-31 S-1 2026-07-31 0001193125-26-328613
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-07-31 S-1 2026-07-31 0001193125-26-328613
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 953,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 56,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 991,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 577,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap AccruedRentCurrent Accrued Rent, Current USD 345,000 2014-03-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.73M 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD 0 2019-03-31 2019 FY 10-K 2019-06-03 0001564590-19-021444
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 1,000 2024-09-30 2025 Q2 10-Q 2024-11-08 0000950170-24-124044
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 160.85M 2014-09-30 2015 Q2 10-Q 2014-11-07 0001193125-14-403624
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 365.04M 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 0 2016-04-01 2017-03-31 2017 FY 10-K 2017-06-07 0001564590-17-012240
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 2,600 2011-07-01 2011-12-31 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 130,000 2026-07-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD -1,925 2010-07-01 2011-06-30 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 38,000 2015-04-01 2016-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 326,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2014-03-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2014-04-01 2015-03-31 2015 FY 10-K 2015-06-09 0001564590-15-004951
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 0 2014-04-01 2015-03-31 2015 FY 10-K 2015-06-09 0001564590-15-004951
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 1,500 2010-01-01 2010-12-31 2012 FY 10-KT 2013-05-24 0001193125-13-235652
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 5.60M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap Assets Assets USD 9.92M 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap AssetsCurrent Assets, Current USD 9.40M 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap AssetsHeldForSaleNotPartOfDisposalGroup Assets Held-for-sale, Not Part of Disposal Group USD 0 2021-03-31 2021 FY 10-K 2021-06-15 0001564590-21-032980
us-gaap AssetsNoncurrent Assets, Noncurrent USD 1.11M 2013-06-30 2013 Q1 10-Q 2013-08-09 0001193125-13-329393
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 2,000 2024-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 0 2024-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 996,000 2024-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 998,000 2024-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-31 0000950170-24-067301
us-gaap CapitalizedComputerSoftwareGross Capitalized Computer Software, Gross USD 244,000 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap CapitalLeaseObligationsCurrent Capital Lease Obligations, Current USD 0 2016-03-31 2016 FY 10-K 2016-06-09 0001564590-16-020442
us-gaap CapitalLeaseObligationsNoncurrent Capital Lease Obligations, Noncurrent USD 0 2015-09-30 2016 Q2 10-Q 2015-11-09 0001564590-15-010138
us-gaap CapitalLeasesFutureMinimumPaymentsDue Capital Leases, Future Minimum Payments Due USD 15,000 2014-03-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 11,000 2014-03-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap CapitalLeasesFutureMinimumPaymentsDueInFourYears Capital Leases, Future Minimum Payments Due in Four Years USD 6,856 2012-09-30 2012 Q3 10-Q 2012-11-14 0001193125-12-470285
us-gaap CapitalLeasesFutureMinimumPaymentsDueInThreeYears Capital Leases, Future Minimum Payments Due in Three Years USD 4,000 2013-03-31 2012 FY 10-KT 2013-05-24 0001193125-13-235652
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 4,000 2014-03-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments Capital Leases, Future Minimum Payments, Interest Included in Payments USD 1,000 2013-03-31 2012 FY 10-KT 2013-05-24 0001193125-13-235652
us-gaap CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments Capital Leases, Future Minimum Payments, Present Value of Net Minimum Payments USD 15,000 2014-03-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap CapitalLeasesIncomeStatementAmortizationExpense Capital Leases, Income Statement, Amortization Expense USD 6,800 2013-04-01 2014-03-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap Cash Cash USD 753 2011-12-31 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 8.56M 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -19.02M 2017-04-01 2018-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 8.71M 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 3.54M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap CertificatesOfDepositAtCarryingValue Certificates of Deposit, at Carrying Value USD 78,800 2014-03-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/Warrant 1 2012-12-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 6.84 2019-09-30 2020 Q2 10-Q 2019-11-07 0001564590-19-041723
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 21.35M 2012-12-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2020-03-31 2020 FY 10-K 2020-05-28 0001564590-20-027310
us-gaap ClassOfWarrantOrRightUnissued Class of Warrant or Right, Unissued shares 100,000 2013-03-31 2012 FY 10-KT 2013-05-24 0001193125-13-235652
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2022-03-31 2022 FY 10-K 2022-06-10 0001564590-22-022994
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 10.38M 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 200.00M 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 18.07M 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 18.07M 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap CommonStockValue Common Stock, Value, Issued USD 18,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -1.81M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 0 2020-03-31 2020 FY 10-K 2020-05-28 0001564590-20-027310
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2020-12-31 2021 Q3 10-Q 2021-02-08 0001564590-21-004687
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2019-03-31 2019 FY 10-K 2019-06-03 0001564590-19-021444
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 0 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-15 0001564590-21-032980
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 704,000 2011-12-31 2012 FY 10-KT 2013-05-24 0001193125-13-235652
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 56,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 134,000 2007-04-19 2014-03-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap CostOfRevenue Cost of Revenue USD 0 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-15 0001564590-21-032980
us-gaap CostOfServicesAmortization Cost of Services, Amortization (Deprecated 2018-01-31) USD 556,000 2014-04-01 2014-12-31 2015 Q3 10-Q 2015-02-06 0001564590-15-000541
us-gaap CostsAndExpenses Costs and Expenses USD 6.14M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 7.68M 2011-10-01 2011-10-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 3.03M 2011-10-01 2011-10-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 239,000 2011-01-01 2011-12-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent Debt Instrument, Convertible, Carrying Amount of Equity Component USD 527,600 2011-12-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap DebtInstrumentConvertibleNumberOfEquityInstruments Debt Instrument, Convertible, Number of Equity Instruments Investment 1.53M 2012-02-01 2012-02-29 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.2 2011-08-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 1.26M 2011-12-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap DebtRelatedCommitmentFeesAndDebtIssuanceCosts Debt Related Commitment Fees and Debt Issuance Costs USD 0 2014-04-01 2015-03-31 2015 FY 10-K 2015-06-09 0001564590-15-004951
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD -1,000 2024-10-01 2024-12-31 2025 Q3 10-Q 2026-02-11 0001193125-26-046520
us-gaap DebtSecuritiesUnrealizedGainLoss Debt Securities, Unrealized Gain (Loss) USD 0 2022-04-01 2022-09-30 2023 Q2 10-Q 2022-11-10 0001564590-22-037381
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 40,000 2014-03-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 0 2013-03-31 2012 FY 10-KT 2013-05-24 0001193125-13-235652
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 117,000 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap DeferredRentCredit Deferred Rent Credit USD 600,000 2019-04-01 2020 FY 10-K 2020-05-28 0001564590-20-027310
us-gaap DeferredRentCreditCurrent Deferred Rent Credit, Current USD 0 2020-03-31 2020 FY 10-K 2020-05-28 0001564590-20-027310
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 0 2020-03-31 2020 FY 10-K 2020-05-28 0001564590-20-027310
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 8,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 19,000 2018-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 93,000 2018-04-01 2018-09-30 2019 Q2 10-Q 2018-11-08 0001564590-18-028535
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 861,000 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 3.11M 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 0 2022-03-31 2022 FY 10-K 2022-06-10 0001564590-22-022994
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 0 2025-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 117,000 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 0 2022-03-31 2022 FY 10-K 2022-06-10 0001564590-22-022994
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 222.20M 2025-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 326,000 2017-03-31 2017 FY 10-K 2017-06-07 0001564590-17-012240
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 44.30M 2025-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 342,000 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 78,000 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 4,000 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 3.00M 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap DefinedBenefitPlanAdministrationExpenses Defined Benefit Plan, Plan Assets, Administration Expense USD 71,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.06 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap Depreciation Depreciation USD 200,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 75,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 32.74M 2012-12-31 2015 FY 10-K 2015-06-09 0001564590-15-004951
us-gaap DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net USD 0 2017-04-01 2018-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 0 2017-03-31 2017 FY 10-K 2017-06-07 0001564590-17-012240
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 1.27M 2011-12-31 2012 FY 10-KT 2013-05-24 0001193125-13-235652
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 122.30M 2015-03-31 2015 FY 10-K 2015-06-09 0001564590-15-004951
us-gaap DilutiveSecurities Dilutive Securities, Effect on Basic Earnings Per Share USD 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.17 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.32 2021-04-01 2022-03-31 2022 FY 10-K 2022-06-10 0001564590-22-022994
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.17 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.011 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.013 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure -0.247 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.004 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.007 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0 2019-04-01 2020-03-31 2020 FY 10-K 2020-05-28 0001564590-20-027310
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 75,000 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.03 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.002 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.004 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.013 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.004 2022-04-01 2023-03-31 2023 FY 10-K 2023-07-14 0000950170-23-032889
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 11,000 2017-04-01 2018-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 0 2018-04-01 2019-03-31 2019 FY 10-K 2019-06-03 0001564590-19-021444
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 340,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 400,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap EquitySecuritiesFvNi Equity Securities, FV-NI USD 0 2024-03-31 2024 FY 10-K 2024-05-31 0000950170-24-067301
us-gaap EquitySecuritiesFvNiGainLoss Equity Securities, FV-NI, Gain (Loss) USD 94,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap EquitySecuritiesFvNiRealizedLoss Equity Securities, FV-NI, Realized Loss USD 5,000 2022-04-01 2022-06-30 2023 Q1 10-Q 2022-08-11 0001564590-22-029133
us-gaap EquitySecuritiesFvNiUnrealizedLoss Equity Securities, FV-NI, Unrealized Loss USD 100,000 2022-04-01 2022-12-31 2023 Q3 10-Q 2023-02-09 0000950170-23-002327
us-gaap EscrowDeposit Escrow Deposit USD 1.00M 2026-07-31 2027 Q1 10-Q 2026-08-12 0001193125-26-346820
us-gaap ExpenseRelatedToDistributionOrServicingAndUnderwritingFees Expense Related to Distribution or Servicing and Underwriting Fees USD 3.20M 2013-08-01 2013-08-02 2016 FY 10-K 2016-06-09 0001564590-16-020442
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 0 2017-04-01 2018-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap FairValueAssumptionsExercisePrice Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) USD 1 2012-09-30 2012 Q3 10-Q 2012-11-14 0001193125-12-470285
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 1.101 2012-01-01 2012-12-31 2012 FY 10-KT 2013-05-24 0001193125-13-235652
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 66,000 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD 0 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-31 0000950170-24-067301
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 5.00M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap GainLossOnSalesOfAssetsAndAssetImpairmentCharges Gain (Loss) on Sale of Assets and Asset Impairment Charges USD 0 2019-04-01 2019-06-30 2020 Q1 10-Q 2019-08-08 0001564590-19-030763
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD 0 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-15 0001564590-21-032980
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 41,145 2009-12-16 2011-12-31 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap GrantsReceivable Grants Receivable USD 0 2020-03-31 2020 FY 10-K 2020-05-28 0001564590-20-027310
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -13.84M 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -13.84M 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -252,693 2009-12-16 2011-12-31 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap IncomeTaxesPaid Income Taxes Paid USD 3,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 3,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 152,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD -32,000 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -2.91M 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 2.27M 2021-04-01 2022-03-31 2022 FY 10-K 2022-06-10 0001564590-22-022994
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 55,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -18,000 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 0 2019-04-01 2020-03-31 2020 FY 10-K 2020-05-28 0001564590-20-027310
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -21,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 59,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 179,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 0 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -68,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 61,198 2009-12-16 2011-12-31 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 16,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -95,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2020-04-01 2021-03-31 2021 FY 10-K 2021-06-15 0001564590-21-032980
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 47,000 2017-04-01 2018-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 30,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -140,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 2,500 2009-12-16 2011-12-31 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 88,000 2007-04-20 2013-03-31 2012 FY 10-KT 2013-05-24 0001193125-13-235652
us-gaap IncreaseDecreaseInRestructuringReserve Increase (Decrease) in Restructuring Reserve USD 341,000 2019-04-01 2019-12-31 2020 Q3 10-Q 2020-02-10 0001564590-20-004042
us-gaap IncreaseInRestrictedCash Increase in Restricted Cash USD 0 2017-04-01 2017-12-31 2018 Q3 10-Q 2018-02-08 0001564590-18-001682
us-gaap InterestExpense Interest Expense USD 0 2016-04-01 2017-03-31 2017 FY 10-K 2017-06-07 0001564590-17-012240
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 4,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2017-04-01 2018-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 4,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 24,000 2011-12-31 2012 FY 10-KT 2013-05-24 0001193125-13-235652
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 0 2023-03-31 2024 FY 10-K 2024-05-31 0000950170-24-067301
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 129,000 2019-03-31 2020 FY 10-K 2020-05-28 0001564590-20-027310
us-gaap InventoryGross Inventory, Gross USD 0 2020-03-31 2020 FY 10-K 2020-05-28 0001564590-20-027310
us-gaap InventoryNet Inventory, Net USD 30,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 82,000 2013-12-31 2013 Q3 10-Q 2014-02-06 0001193125-14-038955
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 361,000 2019-03-31 2020 FY 10-K 2020-05-28 0001564590-20-027310
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 200,000 2024-09-30 2025 Q2 10-Q 2024-11-08 0000950170-24-124044
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 60,000 2012-12-31 2012 FY 10-KT 2013-05-24 0001193125-13-235652
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 0 2019-03-31 2020 FY 10-K 2020-05-28 0001564590-20-027310
us-gaap InventoryWriteDown Inventory Write-down USD 0 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 82,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap Investments Investments USD 0 2025-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 528,000 2007-04-19 2014-03-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 18,000 2021-04-01 2021-09-30 2022 Q2 10-Q 2021-11-08 0001564590-21-055246
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 0 2020-03-31 2020 FY 10-K 2020-05-28 0001564590-20-027310
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 185,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 0 2023-03-31 2023 FY 10-K 2023-07-14 0000950170-23-032889
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 459,000 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 461,000 2022-03-31 2022 FY 10-K 2022-06-10 0001564590-22-022994
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 460,000 2024-03-31 2024 FY 10-K 2024-05-31 0000950170-24-067301
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 538,000 2024-03-31 2024 FY 10-K 2024-05-31 0000950170-24-067301
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 185,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 133,000 2024-12-31 2025 Q3 10-Q 2025-02-19 0000950170-25-022778
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 3,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap Liabilities Liabilities USD 2.68M 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 9.92M 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.68M 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap LiabilityForUncertainTaxPositionsNoncurrent Liability for Uncertainty in Income Taxes, Noncurrent USD 1.80M 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 300,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap LossContingencyAccrualAtCarryingValue Loss Contingency Accrual USD 600,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap LossContingencyAccrualCarryingValueCurrent Loss Contingency, Accrual, Current USD 353,000 2024-12-31 2025 Q3 10-Q 2025-02-19 0000950170-25-022778
us-gaap LossContingencyAccrualProductLiabilityNet Loss Contingency Accrual, Product Liability, Net USD 200,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap MachineryAndEquipmentGross Machinery and Equipment, Gross USD 1.63M 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 3.30M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 10.11M 2017-04-01 2018-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 5.93M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -292,000 2017-04-01 2018-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -5.69M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -28.86M 2017-04-01 2018-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -1.81M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 7.80M 2014-04-01 2014-06-30 2015 Q1 10-Q 2014-08-08 0001193125-14-303337
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 4.26M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap NotesPayableCurrent Notes Payable, Current USD 9,500 2011-12-31 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap OperatingExpenses Operating Expenses USD 10.16M 2022-04-01 2022-12-31 2023 Q3 10-Q 2023-02-09 0000950170-23-002327
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -6.08M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap OperatingLeaseCost Operating Lease, Cost USD 252,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 252,000 2023-04-01 2023-09-30 2023 Q2 10-Q 2023-11-09 0000950170-23-062228
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 182,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 182,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap OperatingLeasePayments Operating Lease, Payments USD 275,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 165,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 242,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 6.27M 2019-03-31 2019 FY 10-K 2019-06-03 0001564590-19-021444
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.08M 2019-03-31 2019 FY 10-K 2019-06-03 0001564590-19-021444
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 1.22M 2019-03-31 2019 FY 10-K 2019-06-03 0001564590-19-021444
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 1.18M 2019-03-31 2019 FY 10-K 2019-06-03 0001564590-19-021444
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive Operating Leases, Future Minimum Payments, Due in Rolling Year Five USD 1.03M 2014-12-31 2015 Q3 10-Q 2015-02-06 0001564590-15-000541
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour Operating Leases, Future Minimum Payments, Due in Rolling Year Four USD 1.00M 2014-12-31 2015 Q3 10-Q 2015-02-06 0001564590-15-000541
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree Operating Leases, Future Minimum Payments, Due in Rolling Year Three USD 984,000 2014-12-31 2015 Q3 10-Q 2015-02-06 0001564590-15-000541
us-gaap OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo Operating Leases, Future Minimum Payments, Due in Rolling Year Two USD 979,000 2014-12-31 2015 Q3 10-Q 2015-02-06 0001564590-15-000541
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 1.16M 2019-03-31 2019 FY 10-K 2019-06-03 0001564590-19-021444
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 1.12M 2019-03-31 2019 FY 10-K 2019-06-03 0001564590-19-021444
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 514,000 2019-03-31 2019 FY 10-K 2019-06-03 0001564590-19-021444
us-gaap OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths Operating Leases, Future Minimum Payments, Next Rolling Twelve Months USD 242,000 2014-12-31 2015 Q3 10-Q 2015-02-06 0001564590-15-000541
us-gaap OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRate Operating Leases of Lessee, Contingent Rentals, Basis Spread on Variable Rate pure 0.03 2021-03-31 2021 FY 10-K 2021-06-15 0001564590-21-032980
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.06 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap OtherAssetImpairmentCharges Other Asset Impairment Charges USD 27,723 2009-12-16 2011-12-31 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap OtherAssetsCurrent Other Assets, Current USD 0 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.03M 2021-03-31 2021 FY 10-K 2021-06-15 0001564590-21-032980
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD 0 2018-04-01 2019-03-31 2019 FY 10-K 2019-06-03 0001564590-19-021444
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 0 2018-04-01 2019-03-31 2019 FY 10-K 2019-06-03 0001564590-19-021444
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 0 2025-04-01 2025-12-31 2025 Q3 10-Q 2026-02-11 0001193125-26-046520
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 74,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 30,000 2007-04-20 2013-06-30 2013 Q1 10-Q 2013-08-09 0001193125-13-329393
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 25,000 2021-04-01 2021-12-31 2022 Q3 10-Q 2022-02-14 0001564590-22-004952
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 0 2022-04-01 2023-03-31 2023 FY 10-K 2023-07-14 0000950170-23-032889
us-gaap PaymentsForCommissions Payments for Commissions USD 1.37M 2012-01-01 2012-12-31 2015 FY 10-K 2015-06-09 0001564590-15-004951
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2021-04-01 2022-03-31 2022 FY 10-K 2022-06-10 0001564590-22-022994
us-gaap PaymentsForRestructuring Payments for Restructuring USD 2.57M 2019-04-01 2019-12-31 2020 Q3 10-Q 2020-02-10 0001564590-20-004042
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2015-04-01 2016-03-31 2016 FY 10-K 2016-06-09 0001564590-16-020442
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 0 2022-04-01 2023-03-31 2023 FY 10-K 2023-07-14 0000950170-23-032889
us-gaap PaymentsToAcquireEquitySecuritiesFvNi PaymentsToAcquireEquitySecuritiesFvNi USD 0 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-31 0000950170-24-067301
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2018-04-01 2019-03-31 2019 FY 10-K 2019-06-03 0001564590-19-021444
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 85,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 9.89M 2022-04-01 2022-09-30 2023 Q2 10-Q 2022-11-10 0001564590-22-037381
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2011-12-31 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 25.00M 2026-06-30 2027 Q1 10-Q 2026-08-12 0001193125-26-346820
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2011-12-31 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-06-30 2027 Q1 10-Q 2026-08-12 0001193125-26-346820
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2011-12-31 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap PrepaidExpenseAndOtherAssets Prepaid Expense and Other Assets USD 3,000 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 747,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap PrepaidExpenseAndOtherAssetsNoncurrent Prepaid Expense and Other Assets, Noncurrent USD 2,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 277,000 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap PrepaidInsurance Prepaid Insurance USD 280,000 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap PrepaidRent Prepaid Rent USD 88,000 2019-03-31 2020 FY 10-K 2020-05-28 0001564590-20-027310
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 740,000 2011-07-01 2011-08-31 2015 FY 10-K 2015-06-09 0001564590-15-004951
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 1.80M 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 3,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 3.42M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 32.74M 2012-01-01 2012-12-31 2015 FY 10-K 2015-06-09 0001564590-15-004951
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 4.63M 2007-04-19 2013-12-31 2013 Q3 10-Q 2014-02-06 0001193125-14-038955
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 250,000 2007-04-19 2014-03-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap ProceedsFromSaleOfEquitySecuritiesFvNi ProceedsFromSaleOfEquitySecuritiesFvNi USD 0 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-31 0000950170-24-067301
us-gaap ProceedsFromSaleOfProductiveAssets Proceeds from Sale of Productive Assets USD 5.00M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2021-04-01 2022-03-31 2022 FY 10-K 2022-06-10 0001564590-22-022994
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 139,000 2015-04-01 2016-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap ProfessionalFees Professional Fees USD 185,502 2009-12-16 2011-12-31 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -1.81M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 1.94M 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 217,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap PropertyPlantAndEquipmentTransfersAndChanges Property, Plant and Equipment, Transfers and Changes USD 0 2018-04-01 2019-03-31 2019 FY 10-K 2019-06-03 0001564590-19-021444
us-gaap RepaymentsOfDebtAndCapitalLeaseObligations Repayments of Debt and Lease Obligation USD 0 2017-04-01 2018-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 250,000 2007-04-19 2014-03-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 2.23M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 100,000 2019-12-31 2020 Q3 10-Q 2020-02-10 0001564590-20-004042
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 38,300 2012-12-31 2013 Q2 10-Q 2013-11-08 0001193125-13-435186
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 100,000 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap RestrictedCashAndInvestments Restricted Cash and Investments USD 79,000 2014-12-31 2015 Q3 10-Q 2015-02-06 0001564590-15-000541
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 143,000 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Employees 6 2023-08-18 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.24 2023-08-18 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap RestructuringCharges Restructuring Charges USD 380,000 2023-04-01 2023-12-31 2023 Q3 10-Q 2024-02-08 0000950170-24-012754
us-gaap RestructuringCosts Restructuring Costs USD 2.10M 2014-04-01 2015-03-31 2015 FY 10-K 2015-06-09 0001564590-15-004951
us-gaap RestructuringReserve Restructuring Reserve USD 225,000 2019-12-31 2020 Q3 10-Q 2020-02-10 0001564590-20-004042
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -357.81M 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 69,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 554,000 2017-04-01 2018-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap Revenues Revenues USD 4.60M 2017-04-01 2018-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2022-04-01 2023-03-31 2023 FY 10-K 2023-07-14 0000950170-23-032889
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 4.5 2013-08-02 2016 FY 10-K 2016-06-09 0001564590-16-020442
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 224,000 2007-04-19 2014-03-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 3.63M 2017-04-01 2018-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 3.86M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap SeveranceCosts1 Severance Costs USD 400,000 2023-04-01 2024-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 2.55M 2018-04-01 2018-09-30 2019 Q2 10-Q 2018-11-08 0001564590-18-028535
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 0 2023-04-01 2023-06-30 2023 Q1 10-Q 2023-08-10 0000950170-23-041307
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 0 2014-04-01 2014-12-31 2015 Q3 10-Q 2015-02-06 0001564590-15-000541
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.4 2012-01-01 2012-09-30 2012 Q3 10-Q 2012-11-14 0001193125-12-470285
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 315,995 2014-12-31 2015 Q3 10-Q 2015-02-06 0001564590-15-000541
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 205,000 2014-04-01 2014-12-31 2015 Q3 10-Q 2015-02-06 0001564590-15-000541
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.12 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 8,647 2014-04-01 2014-12-31 2015 Q3 10-Q 2015-02-06 0001564590-15-000541
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures shares 164,243 2013-04-01 2013-12-31 2013 Q3 10-Q 2014-02-06 0001193125-14-038955
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations shares 52,500 2014-04-01 2014-12-31 2015 Q3 10-Q 2015-02-06 0001564590-15-000541
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 7.45M 2013-06-30 2013 Q1 10-Q 2013-08-09 0001193125-13-329393
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 896,256 2013-06-30 2013 Q1 10-Q 2013-08-09 0001193125-13-329393
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 89,921 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 28.91 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2025-04-01 2025-12-31 2025 Q3 10-Q 2026-02-11 0001193125-26-046520
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 2,552 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 14.51 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 596 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 0 2023-07-01 2023-09-30 2025 Q2 10-Q 2024-11-08 0000950170-24-124044
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 10,039 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.01 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 270,527 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 12 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 0 2019-04-01 2019-06-30 2020 Q1 10-Q 2019-08-08 0001564590-19-030763
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 0 2022-04-01 2023-03-31 2023 FY 10-K 2023-07-14 0000950170-23-032889
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 200,000 2016-04-01 2017-03-31 2017 FY 10-K 2017-06-07 0001564590-17-012240
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-31 0000950170-24-067301
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 4.23 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.19 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap SharePrice Share Price USD/shares 2.05 2012-09-30 2012 Q3 10-Q 2012-11-14 0001193125-12-470285
us-gaap SharesOutstanding Shares, Outstanding shares 0 2011-12-31 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap SharesPaidForTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation shares 305,000 2013-04-01 2013-12-31 2013 Q3 10-Q 2014-02-06 0001193125-14-038955
us-gaap ShortTermInvestments Short-term Investments USD 9.96M 2022-09-30 2023 Q2 10-Q 2022-11-10 0001564590-22-037381
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2022-04-01 2023-03-31 2023 FY 10-K 2023-07-14 0000950170-23-032889
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 100 2009-12-16 2010-06-30 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 7.24M 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 7.24M 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.083 2024-04-01 2025-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions shares 21.25M 2012-02-01 2012-03-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 0 2018-04-01 2019-03-31 2019 FY 10-K 2019-06-03 0001564590-19-021444
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 162,340 2017-04-01 2018-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 0 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-31 0000950170-24-067301
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited Stock Issued During Period, Shares, Restricted Stock Award, Forfeited shares 24,690 2013-01-01 2013-03-31 2012 FY 10-KT 2013-05-24 0001193125-13-235652
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 0 2012-04-01 2012-06-30 2013 Q1 10-Q 2013-08-09 0001193125-13-329393
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensation Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture shares 1.73M 2008-01-01 2008-12-31 2012 Q1 10-Q 2012-05-15 0001193125-12-234370
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2023-04-01 2024-03-31 2024 FY 10-K 2024-05-31 0000950170-24-067301
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 3.49M 2011-01-01 2011-12-31 2014 FY 10-K 2014-06-10 0001193125-14-232145
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 2,000 2010-07-01 2011-06-30 2012 Q2 10-Q 2012-01-17 0001213900-12-000211
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures Stock Issued During Period, Value, Restricted Stock Award, Forfeitures USD 0 2015-04-01 2016-03-31 2018 FY 10-K 2018-05-31 0001564590-18-014814
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 0 2013-04-01 2014-03-31 2016 FY 10-K 2016-06-09 0001564590-16-020442
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2013-04-01 2014-03-31 2015 FY 10-K 2015-06-09 0001564590-15-004951
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 42,000 2020-04-01 2021-03-31 2022 FY 10-K 2022-06-10 0001564590-22-022994
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 3 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 0 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap TreasuryStockRetiredCostMethodAmount Treasury Stock, Retired, Cost Method, Amount USD 0 2025-04-01 2025-06-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 46 2020-08-01 2020-08-31 2021 Q3 10-Q 2021-02-08 0001564590-21-004687
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 1,000 2020-04-01 2021-03-31 2022 FY 10-K 2022-06-10 0001564590-22-022994
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD -27.37M 2007-04-19 2013-12-31 2013 Q3 10-Q 2014-02-06 0001193125-14-038955
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-03-31 2025 FY 10-K 2025-06-05 0000950170-25-082312
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 190,000 2025-04-01 2026-03-31 2026 FY 10-K 2026-07-14 0001193125-26-303316
us-gaap VariableLeaseCost Variable Lease, Cost USD 73,000 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 0 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 10.87M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 8.70M 2021-04-01 2022-03-31 2022 FY 10-K 2022-06-10 0001564590-22-022994
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 10.87M 2026-04-01 2026-09-30 2027 Q2 10-Q 2026-11-12 0001193125-26-458330
us-gaap WeightedAverageNumberOfSharesOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) shares 31.59M 2012-03-31 2012 Q1 10-Q 2012-05-15 0001193125-12-234370

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →